These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


84 related items for PubMed ID: 8287706

  • 21. Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.
    Giordani L, Quaranta MG, Marchesi A, Straface E, Pietraforte D, Villani A, Malorni W, Del Principe D, Viora M.
    Clin Exp Immunol; 2011 Mar; 163(3):346-53. PubMed ID: 21175593
    [Abstract] [Full Text] [Related]

  • 22. Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.
    Falcini F, Cerinic MM, Ermini M, Generini S, Lombardi A, Pignone A, Leoncini G, Tirassa P, Aloe L.
    J Rheumatol; 1996 Oct; 23(10):1798-802. PubMed ID: 8895162
    [Abstract] [Full Text] [Related]

  • 23. Significance of serum immunoglobulin G for leukocytosis and prognosis in childhood B-lineage acute lymphoblastic leukemia.
    Potapnev MP, Belevtsev MV, Bortkevich LG, Grinev VV, Martsev SP, Kravchuk ZI, Migal NV, Aleinikova OV.
    Pediatr Blood Cancer; 2004 May; 42(5):421-6. PubMed ID: 15049013
    [Abstract] [Full Text] [Related]

  • 24. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
    Kim WU, Yoo WH, Park W, Kang YM, Kim SI, Park JH, Lee SS, Joo YS, Min JK, Hong YS, Lee SH, Park SH, Cho CS, Kim HY.
    J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
    [Abstract] [Full Text] [Related]

  • 25. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.
    Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, Taniguchi N.
    Clin Exp Immunol; 1989 Jun; 76(3):337-42. PubMed ID: 2473858
    [Abstract] [Full Text] [Related]

  • 26. Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.
    Kobayashi T, Kimura H, Okada Y, Inoue Y, Kobayashi T, Shinohara M, Morikawa A.
    Clin Exp Immunol; 2007 Apr; 148(1):112-8. PubMed ID: 17286760
    [Abstract] [Full Text] [Related]

  • 27. [Plasma interleukin-10 levels in Kawasaki disease].
    Hirao J, Hibi S, Andoh T, Ichimura T.
    Arerugi; 1996 Apr; 45(4):409-12. PubMed ID: 8687289
    [Abstract] [Full Text] [Related]

  • 28. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A, Rönnelid J, Gunnarsson I, Karlsson G, Berg L, Lundberg I.
    J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
    [Abstract] [Full Text] [Related]

  • 29. Increased serum interleukin-10 level in Kawasaki disease.
    Kim DS, Lee HK, Noh GW, Lee SI, Lee KY.
    Yonsei Med J; 1996 Apr; 37(2):125-30. PubMed ID: 8711935
    [Abstract] [Full Text] [Related]

  • 30. Immunoglobulin G subclasses in serum and circulating immune complexes in patients with Kawasaki syndrome.
    Li CR, Yang XQ, Shen J, Li YB, Jiang LP.
    Pediatr Infect Dis J; 1990 Aug; 9(8):544-7. PubMed ID: 2235169
    [Abstract] [Full Text] [Related]

  • 31. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
    Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann-Liang R.
    J Clin Immunol; 2001 May; 21(3):193-9. PubMed ID: 11403226
    [Abstract] [Full Text] [Related]

  • 32. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
    Hirono K, Foell D, Xing Y, Miyagawa-Tomita S, Ye F, Ahlmann M, Vogl T, Futatani T, Rui C, Yu X, Watanabe K, Wanatabe S, Tsubata S, Uese K, Hashimoto I, Ichida F, Nakazawa M, Roth J, Miyawaki T.
    J Am Coll Cardiol; 2006 Sep 19; 48(6):1257-64. PubMed ID: 16979015
    [Abstract] [Full Text] [Related]

  • 33. Tumor necrosis factor-alpha and interleukin-6 profiles in children with pneumonia.
    Wang CM, Tang RB, Chung RL, Hwang BT.
    J Microbiol Immunol Infect; 1999 Dec 19; 32(4):233-8. PubMed ID: 10650487
    [Abstract] [Full Text] [Related]

  • 34. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
    Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, Deitch EA.
    Crit Care Med; 2003 Jun 19; 31(6):1722-9. PubMed ID: 12794411
    [Abstract] [Full Text] [Related]

  • 35. Serum interleukin-6 in Kawasaki disease.
    Kim DS.
    Yonsei Med J; 1992 Jun 19; 33(2):183-8. PubMed ID: 1413896
    [Abstract] [Full Text] [Related]

  • 36. Distinct variations of antibody secreting cells and memory B cells during the course of Kawasaki disease.
    Xu M, Jiang Y, Wang J, Liu J, Liu C, Liu D, Yang S.
    BMC Immunol; 2019 Jun 03; 20(1):16. PubMed ID: 31159728
    [Abstract] [Full Text] [Related]

  • 37. Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease.
    Shingadia D, O'Gorman M, Rowley AH, Shulman ST.
    Pediatr Res; 2001 Oct 03; 50(4):538-43. PubMed ID: 11568300
    [Abstract] [Full Text] [Related]

  • 38. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.
    Feng S, Su Y, Luo L, Jing F, Yi Q.
    Pediatr Res; 2018 May 03; 83(5):999-1003. PubMed ID: 29360808
    [Abstract] [Full Text] [Related]

  • 39. Abnormalities of immunoregulation in Kawasaki syndrome.
    Barron K, DeCunto C, Montalvo J, Orson F, Lewis D.
    J Rheumatol; 1988 Aug 03; 15(8):1243-9. PubMed ID: 3054095
    [Abstract] [Full Text] [Related]

  • 40. [Peripheral blood monocyte/macrophages among mononuclear cells and serum tumor necrosis factor in patients with Kawasaki disease].
    Matsubara T.
    Arerugi; 1988 Jul 03; 37(7):454-60. PubMed ID: 3214289
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.